BJL
ONC icon

Brighton Jones LLC’s BeOne Medicines Ltd ONC Stock Holding History

Brighton Jones LLC’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,727
Closed -$336K – 315
2020
Q1 		$336K Sell
2,727
-300
-10% -$46.9K 0.04% 195
2019
Q4 		$502K Sell
3,027
-273
-8% -$45.4K 0.05% 175
2019
Q3 		$404K Buy
+3,300
New +$438K 0.05% 187

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Brighton Jones LLC's ONC Position: Q2 2020 in Review

Brighton Jones LLC sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 2,727 shares — an estimated $336K sold.

Brighton Jones LLC first reported a position in ONC in Q3 2019 and held it in 3 quarters. The position peaked at $502K in Q4 2019. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Brighton Jones LLC reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Brighton Jones LLC sold 2,727 BeOne Medicines Ltd shares in Q2 2020, an estimated $336K.
  • Brighton Jones LLC first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 3 quarters.
  • Brighton Jones LLC's BeOne Medicines Ltd position peaked at $502K in Q4 2019.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Brighton Jones LLC's 13F filing for Q2 2020, filed 11 Aug 2020.